Amedisys
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Amedisys generated cash of $137,188,000, which is more than the previous year. Cash used in financing activities reached the amount of -$87,522,000 last year. Net change in cash is therefore $84,730,000.
Cash Flow
| 2014 | -65.53M | -14.3M | 70.56M |
|---|---|---|---|
| 2015 | 107.78M | -67.42M | -20.89M |
| 2016 | 62.25M | -52.04M | -7.51M |
| 2017 | 105.73M | -44.02M | -5.53M |
| 2018 | 223.48M | -22.19M | -267.42M |
| 2019 | 202M | -352.94M | 227.20M |
| 2020 | 288.95M | -287.10M | -14.97M |
| 2021 | 188.89M | -281.60M | 55.12M |
| 2022 | 133.28M | -94.48M | -30.43M |
| 2023 | 137.18M | 35.06M | -87.52M |
AMED Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 54.13M | 45.76M | 83.35M | 96.49M | 20.22M | 86.36M | 30.19M | 27.50M | 8.03M | 17.30M |
Operating activities | ||||||||||
Net income | -9.74M | 117.69M | 210.16M | 185.18M | 127.90M | 120.12M | 30.68M | 37.63M | -2.31M | 13.08M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 57.84M | 70.96M | 71.26M | 67.94M | 54.33M | 13.26M | 17.12M | 19.67M | 20.03M | 28.34M |
Stock-based compensation expense | 29.02M | 16.55M | 23.80M | 26.73M | 35.54M | 0 | 16.29M | 16.40M | 11.82M | 5.59M |
| Deferred income tax benefit | 29.02M | 16.55M | 23.80M | 26.73M | 35.54M | 0 | 16.29M | 16.40M | 11.82M | 5.59M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -26.72M | -14.23M | -18.03M | 2.11M | -24.14M | 12.22M | -59.73M | -55.51M | -36.49M | -5.29M |
Inventories | 0 | 0 | 0 | -2.03M | 7.11M | 22.20M | 26.90M | -3.38M | 14.86M | -152.77M |
Accounts payable | -15.81M | 4.89M | -4.35M | 1.94M | -11.32M | 3.16M | -2.84M | 3.97M | 7.63M | -3.16M |
Cash generated by operating activities | 137.18M | 133.28M | 188.89M | 288.95M | 202M | 223.48M | 105.73M | 62.25M | 107.78M | -65.53M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -15M | -5.2M | -875K | -210K | -7.14M | -476K | -1.04M | -3.48M | -6.40M |
Investments In Property Plant And Equipment | -5.62M | -7.21M | -6.72M | -5.33M | -7.88M | -6.55M | -10.70M | -15.71M | -21.42M | -12.00M |
Acquisitions Net | 47.43M | -72.58M | -269.96M | -281.08M | -345.46M | -9.26M | -33.71M | -35.52M | -68.71M | 4.23M |
Cash generated by investing activities | 35.06M | -94.48M | -281.60M | -287.10M | -352.94M | -22.19M | -44.02M | -52.04M | -67.42M | -14.3M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 3.96B | 3.56B | 0 | 2.42M | 0 | 2.48M | 0 | 2.43B |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -6.52M | -25.33M | -116.77M | -54.49M | -9.55M | -187.97M | -6.93M | -12.31M | -4.58M | 0 |
Repayments of term debt | -76.01M | 0 | -551.7M | -703.2M | 237.5M | -130.5M | 0 | -134.5M | 85M | -226.8M |
Cash used in financing activities | -87.52M | -30.43M | 55.12M | -14.97M | 227.20M | -267.42M | -5.53M | -7.51M | -20.89M | 70.56M |
Net Change In Cash | 84.73M | 8.36M | -37.58M | -13.13M | 76.26M | -66.13M | 56.16M | 2.69M | 19.47M | -9.27M |
Cash at end of period | 138.86M | 54.13M | 45.76M | 83.35M | 96.49M | 20.22M | 86.36M | 30.19M | 27.50M | 8.03M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |